KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alto Ingredients (ALTO) Cash from Financing Activities (2016 - 2025)

Alto Ingredients (ALTO) has 15 years of Cash from Financing Activities data on record, last reported at -$18.5 million in Q3 2025.

  • For Q3 2025, Cash from Financing Activities fell 120.43% year-over-year to -$18.5 million; the TTM value through Sep 2025 reached $14.2 million, up 429.71%, while the annual FY2024 figure was $7.7 million, 10.87% up from the prior year.
  • Cash from Financing Activities reached -$18.5 million in Q3 2025 per ALTO's latest filing, down from $6.9 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $25.4 million in Q4 2022 and bottomed at -$40.8 million in Q4 2021.
  • Average Cash from Financing Activities over 5 years is -$48210.5, with a median of $3.7 million recorded in 2023.
  • Peak YoY movement for Cash from Financing Activities: crashed 993.85% in 2021, then surged 1309.7% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at -$40.8 million in 2021, then soared by 162.21% to $25.4 million in 2022, then tumbled by 85.27% to $3.7 million in 2023, then soared by 134.7% to $8.8 million in 2024, then tumbled by 310.62% to -$18.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Financing Activities were -$18.5 million in Q3 2025, $6.9 million in Q2 2025, and $17.0 million in Q1 2025.